Cbay stock forecast.
A price increase of 4.1% over the past four weeks ensures that the trend is still in place for the stock of this company. Moreover, CBAY is currently trading at 91.3% of its 52-week High-Low Range ...
Analyst Forecast According to 10 analysts, the average rating for BMEA stock is "Strong Buy." The 12-month stock price forecast is $47.7, which is an increase of 185.97% from the latest price.CymaBay Therapeutics Inc. 18.65. Delayed Data. As of Nov 20. +0.30 / +1.63%. Today’s Change. 3.17. Today ||| 52-Week Range. 18.81.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Industry. Packaged Software. No executives to display. Corporate headquarters. Austin, Texas. Find real-time APPS - Digital Turbine Inc stock quotes, company profile, news and forecasts from CNN ...The stock is selling for $9.87 and its $13.89 average price target suggests a 12-month upside potential of ~41%. (See CBAY stock forecast ) Cerevel Therapeutics ( CERE )
Analyst Forecast According to 10 analysts, the average rating for BMEA stock is "Strong Buy." The 12-month stock price forecast is $47.7, which is an increase of 185.97% from the latest price.
CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline ...
Investors often compare top stocks against the Russell 3000 Index, a broad measure of the U.S. stock market comprising 3,000 large publicly traded companies or 96% of the investable U.S. equity ...He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. Notably, CymaBay stock has a best-possible Relative Strength Rating of 99, according to IBD Digital. This ...Nov 21, 2023 · According to analyst projections, CBAY’s forecast low is $20.00 with $34.00 as the target high. To hit the forecast high, the stock’s price needs a -82.21% plunge from its current level, while the stock would need to soar -7.18% for it to hit the projected low. Cymabay Therapeutics Inc (CBAY) estimates and forecasts PTC Therapeutics Inc. -3.71%. $1.57B. CBAY | Complete CymaBay Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
7 brokers have issued 12-month price targets for Verastem's stock. Their VSTM share price targets range from $21.00 to $36.00. On average, they anticipate the company's share price to reach $29.71 in the next year. This suggests a possible upside of 362.1% from the stock's current price. View analysts price targets for VSTM or view top …
6 analysts have issued 12 month price objectives for Spruce Biosciences' shares. Their SPRB share price targets range from $4.00 to $10.00. On average, they expect the company's share price to reach $7.67 in the next year. This suggests a possible upside of 463.7% from the stock's current price.
Cymabay Therapeutics Inc (NASDAQ:CBAY) trade information. Instantly CBAY has been showing red trend so far today with a performance of -1.24% on intraday trading today. The performance over the last five days has remained in the red territory. The company’s shares are currently up 186.68% year-to-date, but still down -3.67% over the …cbay forecast stock wallpaper. cbay stock forecast cnn. Based on 5 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. CBAY stock quote h… Wednesday, October 26, 2022 Edit.Industry. Packaged Software. No executives to display. Corporate headquarters. Austin, Texas. Find real-time APPS - Digital Turbine Inc stock quotes, company profile, news and forecasts from CNN ...19/11/2021 ... However, analysts give CBAY stock a price target of $11.10, which would be a 179% gain from its current price. CES Energy Solutions (CESDF).Gas prices are at a record high, and experts are forecasting that prices could go higher this summer — perhaps $5 or even over $6 a gallon. By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its partners. I a...
Analyst projections state that BYND is forecast to be at a low of $3.00 and a high of $9.00. In order for the stock price to hit the forecast high, the stock would need to plunge -39.32% from its current level, while the stock would need to crash 53.56% from its current level to reach the projected low. Beyond Meat Inc (BYND) estimates and ...28/12/2022 ... Impact of many factors on the stock prices makes the stock prediction a difficult and highly complicated task.Analyst projections state that BYND is forecast to be at a low of $3.00 and a high of $9.00. In order for the stock price to hit the forecast high, the stock would need to plunge -39.32% from its current level, while the stock would need to crash 53.56% from its current level to reach the projected low. Beyond Meat Inc (BYND) estimates and ...A price increase of 4.1% over the past four weeks ensures that the trend is still in place for the stock of this company. Moreover, CBAY is currently trading at 91.3% of its 52-week High-Low Range ...Based on our forecasts, a long-term increase is expected, the "CBAY" stock price prognosis for 2028-10-27 is 18.476 USD. With a 5-year investment, the revenue is …Dec 1, 2023 · CymaBay Therapeutics (CBAY) Stock Price, News & Analysis $17.90 -0.21 (-1.16%) (As of 11/22/2023 ET) Compare Today's Range $17.82 $18.45 50-Day Range $12.63 $18.66 52-Week Range $3.21 $19.06 Volume 1.15 million shs Average Volume 1.89 million shs Market Capitalization $2.03 billion P/E Ratio N/A Dividend Yield N/A Price Target $22.27
Shares of CymaBay Therapeutics ( CBAY -1.16%) were jumping 14.2% higher as of 10:54 a.m. ET on Friday. This move came on the heels of an 8.5% gain on Thursday. The continued momentum is a result ...7 brokers have issued 12-month price targets for Verastem's stock. Their VSTM share price targets range from $21.00 to $36.00. On average, they anticipate the company's share price to reach $29.71 in the next year. This suggests a possible upside of 362.1% from the stock's current price. View analysts price targets for VSTM or view top-rated ...
Reported on 11/6/23. Get the latest CymaBay Therapeutics Inc (CBAY) real-time quote, historical performance, charts, and other financial information to help you make more …Find the latest Allarity Therapeutics, Inc. (ALLR) stock quote, history, news and other vital information to help you with your stock trading and investing.CDTX Stock 12 Months Forecast. Based on 1 Wall Street analysts offering 12 month price targets for Cidara Therapeutics in the last 3 months. The average price target is $6.00 with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 679.22% change from the last price of $0.77.Dec 1, 2023 · Analyst Forecast According to 10 analysts, the average rating for BMEA stock is "Strong Buy." The 12-month stock price forecast is $47.7, which is an increase of 185.97% from the latest price. CymaBay Therapeutics Stock Forecast and Price Target. If CymaBay Therapeutics's stock price reached the average yearlong target of $10.00 given by five well-known analysts in recent months, there would be a potential downside of approximately -18.57% from its last closing price in July, 2023.Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...Dec 1, 2023 · 6 analysts have issued 12 month price objectives for Spruce Biosciences' shares. Their SPRB share price targets range from $4.00 to $10.00. On average, they expect the company's share price to reach $7.67 in the next year. This suggests a possible upside of 463.7% from the stock's current price. Nov 27, 2023 · See the latest CymaBay Therapeutics Inc stock price (CBAY:XNAS), related news, valuation, dividends and more to help you make your investing decisions. CBAY is a biopharmaceutical company that develops and commercializes new medicines for important human diseases. The stock price, earnings, news, and research reports of CBAY are available on Zacks. See the latest Zacks Rank, Style Scores, EPS Surprise, and more for CBAY.Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...
Nov 27, 2023 · See the latest CymaBay Therapeutics Inc stock price (CBAY:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
6 analysts have issued 12 month price objectives for Spruce Biosciences' shares. Their SPRB share price targets range from $4.00 to $10.00. On average, they expect the company's share price to reach $7.67 in the next year. This suggests a possible upside of 463.7% from the stock's current price.
Xenon Pharmaceuticals Inc. 28.97. +0.24. +0.84%. Get CymaBay Therapeutics Inc (CBAY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.The CymaBay Therapeutics stock forecast for tomorrow is $ 19.01, which would represent a -0.48% loss compared to the current price. In the next week, the price of CBAY is expected to decrease by -5.95% and hit $ 17.96. As far as the long-term CymaBay Therapeutics stock forecast is concerned ... Newark, California-based CymaBay Therapeutics (CBAY) was approved for uplisting to the Nasdaq in June 2014, with stock initially trading at a value of $19. Across the next 9 years they have been ...(See CBAY stock forecast)Cerevel Therapeutics (CERE)The next Edelman choice is Cerevel, a company established in 2018 that specializes in the field of neuroscience. Cerevel's focus is on the ...Insiders who bought CymaBay Therapeutics, Inc. (NASDAQ:CBAY) stock lover the last 12 months are probably not as affected by last week’s 11% loss.After accounting for the recent loss, the US$161k ...(See CBAY stock forecast)Cerevel Therapeutics (CERE)The next Edelman choice is Cerevel, a company established in 2018 that specializes in the field of neuroscience. Cerevel's focus is on the ...Dec 1, 2023 · Analyst Forecast According to 10 analysts, the average rating for BMEA stock is "Strong Buy." The 12-month stock price forecast is $47.7, which is an increase of 185.97% from the latest price. CymaBay Therapeutics Inc (CBAY) stock is trading at $11.76 as of 11:26 AM on Monday, Jul 3, a rise of $0.81, or 7.39% from the previous closing price of $10.95. The stock has traded between $10.95 and $11.77 so far today. Volume today is low. So far 1,522,720 shares have traded compared to average volume of 2,310,531 shares.Track Cymabay Therapeutics Inc (CBAY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Crescent Point Energy Corp have a median target of 10.24, with a high estimate of 13.84 and a low estimate of 8.78. The ...CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company's lead ...
We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...Find the latest CymaBay Therapeutics Inc. CBAY analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.Their CBAY share price targets range from $12.00 to $34.00. On average, they expect the company's stock price to reach $22.27 in the next twelve months. This suggests a possible upside of 13.0% from the stock's current price. View analysts price …Analyst Price Forecast Suggests 15.86% Upside As of August 2, 2023, the average one-year price target for Cymabay Therapeutics is 15.61. The forecasts range from a low of 12.12 to a high of $19.95.Instagram:https://instagram. how can you tell if gold is real at homevision plans in texasvision and dental insurance georgiasilicon valley bank stocks The CymaBay Therapeutics stock forecast for tomorrow is $ 19.01, which would represent a -0.48% loss compared to the current price. In the next week, the price of CBAY is expected to decrease by -5.95% and hit $ 17.96. As far as the long-term CymaBay Therapeutics stock forecast is concerned ... whats inside the las vegas sphereopk shares Forecast . Price target. 24.08 0.00 0.00%. The 12 analysts offering 1 year price forecasts for CBAY have a max estimate of — and a min estimate of —. Analyst rating. Based on 13 analysts giving stock ratings to CBAY in the past 3 months. EPS. Annual Annual Quarterly Quarterly More More mstf stock CPG Stock 12 Months Forecast. Based on 10 Wall Street analysts offering 12 month price targets for Crescent Point Energy in the last 3 months. The average price target is C$14.80 with a high forecast of C$19.00 and a low forecast of C$13.00. The average price target represents a 53.50% change from the last price of C$9.64.Their CBAY share price targets range from $12.00 to $34.00. On average, they expect the company's stock price to reach $22.27 in the next twelve months. This suggests a possible upside of 13.0% from the stock's current price. View analysts price …CBAY Earnings Date and Information. CymaBay Therapeutics last posted its earnings results on November 7th, 2023. The biopharmaceutical company reported ($0.32) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.02.